BioSpace News Archive

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear Pharmaceuticals, Inc. submitted an application for Vicromax(tm_ (merimepodib, or MMPD) through the FDA’s Coronavirus Treatment Acceleration Program (CTAP) to administer the drug to hospitalized patients with COVID-19.

In a white paper, published by the Harvard University Edmond J. Safra Center for Ethics, ID2020 urged policymakers, technology providers, and civil society organizations to collaborate to ensure that digital health credentials or “immunity certificates”, if implemented, are intentionally designed to protect privacy and civil liberties..

Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator and exporter, announces that it has attained medical devices establishment licensing from Health Canada, enabling the immediate usage of its quality assessment products (QAPs™) by clinical laboratories, including its QAPs to help ensure the accuracy of COVID-19 disease testing.

Scientists worldwide are being invited to have their say in the Scientists’ Choice Awards® for the Best New Life Sciences Product of 2019

Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) announced today that the Company has entered into a research collaboration with the Fraunhofer Institute for Cell Therapy and Immunology (IZI) and acquired related patents from the Institute for a meprin protease inhibitor and assay platform.

For more detail related to the fiscal year 2020 unaudited second quarter results, please visit our web site at www.bioqual.com.

Actinium Pharmaceuticals, Inc. announced the pricing of the Company’s previously announced underwritten public offering of 183,333,334 shares of common stock at a public offering price of $0.15 per share of common stock.

ChromaCode joining fight against novel coronavirus; High-Definition PCR SARS-CoV-2 assay to increase test throughput and reduce complexity of interpretation

American Lung Association’s ‘State of the Air’ report finds climate change is driving increases in unhealthy air, 150 million people at risk

Sales revenue up 22.3% in constant currencies, order intake up 39.3%, underlying EBITDA margin1 up 1.4 percentage points to 30.0%